Distribuzione geografica
Continente #
EU - Europa 4.025
Totale 4.025
Nazione #
IT - Italia 4.025
Totale 4.025
Città #
Genova 3.237
Rapallo 444
Genoa 325
Bordighera 19
Totale 4.025
Nome #
PVR(CD155) and Nectin-2 (CD112) as ligands of the human DNAM-1 (CD226) activating receptor: involvement in tumor cell lysis 181
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 176
NK cells and multiple myeloma-associated endothelial cells: molecular interactions and influence of IL-27 160
Natural Killer Cells and Neuroblastoma: Tumor Recognition, Escape Mechanisms, and Possible Novel Immunotherapeutic Approaches. 144
Both CD133(+) and CD133(-) medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity 136
Multi-directional cross-regulation of NK cell function during innate immune responses. 128
Human NK cell infusions prolong survival of metastatic human neuroblastoma-bearing NOD/scid mice. 126
Main NK cell receptors and their ligands: regulation by microRNAs 125
Soluble HLA class I induces NK cell apoptosis upon the engagement of killer-activating HLA class I receptors through FasL-Fas interaction. 120
The interaction of human natural killer cells with either unpolarized or polarized macrophages results in different functional outcomes. 113
Natural killer cell-mediated killing of freshly isolated neuroblastoma cells: critical role of DNAX accessory molecule-1-poliovirus receptor interaction 111
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine and chemokine secretion in CD56bright and CD56dim NK cells. 111
Human NK cells and NK receptors 111
CIS is a negative regulator of IL-15-mediated signals in NK cells 111
Molecular mechanisms directing migration and retention of natural killer cells in human tissues 111
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors 110
PD-L1 expression in metastatic neuroblastoma as an additional mechanism for limiting immune surveillance 106
Small round blue cell tumours: diagnostic and prognostic usefulness of the expression of B7-H3 surface molecule. 100
Neuroblastoma-Derived TGF-beta1 Modulates the Chemokine Receptor Repertoire of Human Resting NK Cells. 98
Expression of the DNAM-1 ligands Nectin-2 (CD112) and poliovirus receptor (CD155) on dendritic cells: relevance for natural killer/dendritic cells interaction 98
Cell-laden hydrogel as a clinical-relevant 3D model for analyzing neuroblastoma growth, immunophenotype, and susceptibility to therapies 98
TLR activation of tumor-associated macrophages from ovarian cancer patients triggers cytolytic activity of NK cells. 98
Novel Immunoregulatory Functions of IL-18, an Accomplice of TGF-β1 97
Neuroblastoma-derived transforming growth factor (TGF) β1 modulates the chemokine receptor repertoire of human resting Natural Killer Cells. 96
It's only innate immunity but I like it 94
Soluble HLA class I molecules induce natural killer cell apoptosis through the engagement of CD8: evidence for a negative regulation exerted by members of the inhibitory receptor superfamily 93
Overview of the Soluble and Membrane-bound Tumor Factors Limiting NKmediated Immune Surveillance 92
Imatinib and nilotinib off-target effects on human NK cells, monocytes, and M2 macrophages 90
Neuroblastoma Cells Modulate Chemokine Receptor Repertoire of Resting NK Cells 89
TGF-beta1 downregulates the expression of CX3CR1 by inducing miR-27a-5p in primary human NK cells 85
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastoma 82
Su.64. Natural Killer Cell-mediated Recognition of Human Brain Tumors 79
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency 76
IFN-gamma production in human NK cells through the engagement of CD8 by soluble or surface HLA class I molecules 74
Identification of a novel neuroblastoma-associated molecule that protects from NK-mediated lysis 72
Identification of 4Ig-B7-H3 as a novel neuroblastoma-associated molecule that exerts a protective role from natural killer cell-mediated lysis 69
Natural Killer cells recognize and kill human glioblastoma cells with stem cell-like properties 58
Soluble HLA-G dampens CD94/NKG2A expression and function and differentially modulates chemotaxis and cytokine /chemokine secretion in CD56(bright) and CD56(dim) NK cells 48
Tumor Microenvironment and Hydrogel-Based 3D Cancer Models for In Vitro Testing Immunotherapies 40
NK Cell Function Regulation by TGF-β-Induced Epigenetic Mechanisms 38
Inhibitory axes impacting on the activity and fate of Innate Lymphoid Cells 38
Multiparametric flow cytometry highlights B7-H3 as a novel diagnostic/therapeutic target in GD2neg/low neuroblastoma variants 36
A multi-organ-on-chip to recapitulate the infiltration and the cytotoxic activity of circulating NK cells in 3D matrix-based tumor model 20
Strategies for Potentiating NK-Mediated Neuroblastoma Surveillance in Autologous or HLA-Haploidentical Hematopoietic Stem Cell Transplants 19
B7-H3 in Pediatric Tumors: Far beyond Neuroblastoma 8
miR-24-3p down-regulates the expression of the apoptotic factors FasL and BIM in human natural killer cells 6
Totale 4.171
Categoria #
all - tutte 11.485
article - articoli 11.003
book - libri 0
conference - conferenze 187
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 295
Totale 22.970

Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019250 0 0 0 0 0 0 0 0 0 47 109 94
2019/20201.154 49 37 38 75 116 124 178 85 107 193 116 36
2020/2021458 23 50 53 32 21 72 10 39 30 59 21 48
2021/2022522 28 31 45 60 10 40 25 115 31 47 28 62
2022/2023541 54 50 6 57 80 94 3 36 105 4 39 13
2023/2024257 17 48 12 55 14 31 15 30 26 9 0 0
Totale 4.171